madindoline (Kitasato Institute)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namemadindoline (Kitasato Institute)
Drug Alias NameIL-6 inhibitors (Kitasato)Madindoline Amadindoline A (Kitasato Institute)Madindoline Bmadindoline B (Kitasato Institute)
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionIL-6 receptor antagonists
TargetsIL-6 receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKitasato Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKitasato Institute
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A